Mode
Text Size
Log in / Sign up

Novel nasal cannula reduces hypoxemia versus face mask during pediatric bronchoscopyA Simple Nasal Tube Cuts Breathing Drops by Two-Thirds in Kids' Lung Procedures

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider novel nasal cannula as a potential alternative to face mask for oxygen delivery in pediatric bronchoscopy, pending further safety data.

This single-center randomized controlled trial compared a novel nasal cannula (NNO) to a conventional face mask (CMO) for oxygen delivery in 199 children with ASA physical status I-II undergoing elective flexible bronchoscopy. The primary outcome was intraoperative hypoxemia, defined as SpO₂ < 90% for more than 10 seconds.

The incidence of hypoxemia was significantly lower in the NNO group (6.0%) than in the CMO group (18.2%), with a relative risk of 0.33 (95% CI 0.14-0.80, p=0.008). The NNO group also maintained a higher minimum SpO₂ (94.9% vs. 93.5%, p=0.003), required fewer mask ventilation interventions (2 vs. 13, p=0.005), and had a significantly prolonged time to first hypoxemic episode (adjusted HR 0.203, 95% CI 0.075-0.547, p=0.002).

Safety was assessed by comparing adverse event rates, but specific rates were not reported. The study did not report on serious adverse events, discontinuations, or tolerability. Key limitations include its single-center design and the lack of detailed safety data, which restricts generalizability and a full risk-benefit assessment.

For practice, this evidence suggests the novel nasal cannula may be a more effective option than a conventional face mask for maintaining oxygenation during pediatric flexible bronchoscopy in healthy children. However, clinicians should interpret these results cautiously due to the single-center nature of the trial and the absence of comprehensive safety reporting. Further multicenter studies with robust safety monitoring are needed to confirm these findings.

The scariest moment in a routine procedure

Bronchoscopy is one of those pediatric procedures parents rarely hear about until they need it. A doctor passes a thin, flexible camera down the airway to look for blockages, infections, or other lung problems.

It's quick. It's usually safe. But during the few minutes the scope is in place, oxygen levels can dip dangerously low.

A new clinical trial suggests a small change in how oxygen is delivered makes a big difference.

Children getting bronchoscopy are often already short of breath because of whatever lung problem brought them in. Add sedation and a camera in the airway, and the margin for error gets thin.

If oxygen drops too low — known as hypoxemia — the procedure may need to be paused, a face mask brought in, and rescue ventilation started. That delays things, raises stress, and adds risk.

For decades, the standard solution has been to give oxygen through a face mask covering the nose and mouth.

The old way versus the new way

Conventional face masks work, but they share the same airway space the scope needs. They get in the way of the doctor's hands and view, and they sometimes don't deliver enough oxygen when the child's mouth is partly open or the seal isn't perfect.

The novel nasal cannula in this trial takes a different approach. It delivers oxygen through the nose, supraglottically — meaning above the vocal cords — without competing for the same opening as the bronchoscope. The doctor gets a cleaner view, and the child gets a steadier flow of oxygen.

How the cannula keeps kids safer

Picture trying to refill a glass of water while someone is also pouring lemonade through the same straw. They get in each other's way, and a lot spills.

A face mask and a bronchoscope share the same opening — the mouth and back of the throat. Each one interferes with the other.

The new nasal cannula uses a separate path. Oxygen enters through the nose and reaches the airway from above. The bronchoscope still goes through the mouth, but now it has the space to itself.

The result is steadier oxygen delivery throughout the procedure, even when the child shifts or the scope passes a tight area.

The study snapshot

Researchers ran a randomized clinical trial in 199 children scheduled for elective flexible bronchoscopy. About half were randomly assigned to the new nasal cannula and the other half to the standard face mask. The team measured how often oxygen levels dropped below 90% for more than 10 seconds — the definition of hypoxemia — along with the lowest oxygen reading, the time before any drop happened, and how often emergency mask ventilation was needed.

Dangerous oxygen drops happened in only 6.0% of children using the nasal cannula compared to 18.2% using the standard face mask — a roughly two-thirds reduction.

The lowest oxygen level any child reached was higher in the nasal cannula group. Time before any oxygen dip was significantly longer. And emergency mask ventilation was needed only twice in the cannula group versus 13 times in the face mask group.

Importantly, no extra side effects were seen in the new device. The doctors also reported a clearer view and easier access to the airway, which makes the procedure faster and safer.

This isn't a magic device for every airway procedure.

Where this fits in the bigger picture

Pediatric anesthesia has been quietly improving for decades. Tools that once worked "well enough" in adults are getting redesigned for the smaller airways and faster physiology of children.

This nasal cannula fits that pattern. It's a relatively simple piece of equipment that solves a real problem — sharing the airway with another instrument — without adding cost or complexity. The data suggest that swapping it in could prevent thousands of stressful hypoxic moments each year worldwide.

If your child is scheduled for bronchoscopy or another short airway procedure, this study won't change anything you need to do as a parent. The decision about how oxygen is delivered is made by the anesthesia and pulmonary teams.

But it's reasonable to ask whether your hospital uses newer oxygen delivery methods designed specifically for procedures like this. As more centers adopt this kind of device, parents may notice fewer pauses and shorter recovery times after the procedure.

The trial was done at a single hospital with 199 children. All were considered low-risk under standard anesthesia classifications. Results may differ for sicker children, very young infants, or those with abnormal airways. Larger multi-center trials would help confirm how widely the benefit applies.

The team and others are now planning trials in higher-risk children and in other procedures where airway sharing causes problems, such as upper endoscopy and laryngeal surgery. If the results hold up in those settings, this kind of nasal cannula could become standard equipment in pediatric procedure suites.

Study Details

Study typeRct
EvidenceLevel 2
PublishedMar 2026
View Original Abstract ↓
UNLABELLED: Maintaining adequate oxygenation during pediatric bronchoscopy is critical for patient safety and procedural success. This study evaluates a novel supraglottic oxygen delivery technique designed to improve intraoperative oxygenation via a less invasive, more efficient approach. In this single-center, prospective, randomized controlled trial, children undergoing elective bronchoscopy were randomly assigned to receive oxygen through a novel nasal cannula (NNO) or conventional face mask (CMO), using computer-generated allocation sequences with concealed envelopes. The primary outcome was intraoperative hypoxemia (SpO₂ < 90% for > 10 s). Secondary outcomes included minimum SpO₂, severe hypoxemia (SpO₂ < 80%), frequency of mask ventilation due to desaturation, operator satisfaction with airway access and visual field, and time to first hypoxemic episode. Safety was assessed by comparing adverse event rates. In the intention-to-treat analysis of 199 randomized children, the incidence of hypoxemia was significantly lower in the NNO group than in the CMO group (6.0% vs. 18.2%; RR = 0.33, 95% CI 0.14-0.80; p = 0.008). Per-protocol analysis yielded consistent results (5.1% vs. 20.5%; p = 0.001). After multivariable adjustment, NNO remained a significant independent protective factor against hypoxemia (aOR = 0.272, 95% CI 0.098-0.753; p = 0.012). Secondary outcomes also favored NNO: lowest recorded SpO₂ was higher (94.9% vs. 93.5%, p = 0.003), mask interventions were fewer (2 vs. 13, p = 0.005), and time to hypoxemia was significantly prolonged (aHR = 0.203, 95% CI 0.075-0.547; p = 0.002). CONCLUSION: In children with American Society of Anesthesiologists (ASA) physical status I-II undergoing flexible bronchoscopy, the novel nasal cannula was more effective than the conventional face mask in preventing hypoxemia and reducing procedural interruptions. TRIAL REGISTRATION: The Chinese Clinical Trial Registry (chiCTR.gov): No. ChiCTR2500113734, Retrospectively registered, Date of registration: December 2, 2025. WHAT IS KNOWN: • Maintaining adequate oxygenation is essential for ensuring patient safety and procedural success during pediatric flexible bronchoscopy. • Conventional face masks (CMO) are widely used for oxygen delivery; however, they may be insufficient in preventing intraoperative hypoxemia. WHAT IS NEW: • A novel nasal cannula (NNO) significantly reduces the incidence of hypoxemia (6.0% vs. 18.2%) compared to CMO in children undergoing flexible bronchoscopy. • The use of NNO is associated with higher minimum SpO₂ levels, a longer time to onset of first hypoxemic event, and fewer procedural interruptions due to rescue ventilation, thereby providing a less invasive and more effective oxygenation strategy.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.